Articles tagged “sandals”

The all-inclusive operator's executive chairman says he isn't selling the company, despite rumors, but is instead pouring tens of millions into properties to drive rate premiums.

The collapse of Jamaica’s peak tourism season after Hurricane Melissa shows how unprepared the industry remains for extreme weather. Building climate resilience is no longer optional.

Sandals Resorts, the Caribbean luxury all-inclusive operator, is said to be restarting sale efforts a few years after its founder's death. The potential move comes as the brand makes a multi-million dollar marketing push.

Now that all the big hotel chains are muscling into the all-inclusive space, Sandals aims to stand out by reminding travelers of its Caribbean roots.

In this video from Skift Global Forum 2022, we hear from Adam Stewart, executive chairman of Sandals Resorts International (SRI), on the importance of investing in the next generation of talent during a critical, transitional time in the hospitality industry.

Watch out for the quiet ones. Choice didn't run any U.S. national TV ads in 2021 and Virgin Voyages was absent during the first seven months of last year. Yet both brands surged to leadership positions in 2022.

You can debate the degree to which cities will come back and the future grip of remote work, but it seems clear that video advertising will remain on a new perch for awhile.

In Skift's top travel stories this week, we covered Marriott's arrival in Sandals' all-inclusive sandbox, travel manager fears over consolidation, and a startup deal on hotel automation.

Luxury all-inclusive resorts may be optimistic about the future post-pandemic, but profits will come alongside heightened green challenges. Then there's an increasingly demanding, socially conscious consumer. Can the resorts return to their former stature as the fast-growing sector of accommodations?

The most popular travel ads on TV in the United States in July were aspirational, but they also emphasized booking flexibility and low pricing. Pandemic formulations.